Company Data
Curis Inc.
Ticker
CRIS
Current Price
$0.603 2.01%
Market Cap
$24.1M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$0.490201 - $3.13
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.